In This Issue:
Capitol Hill Update
House Democratic leadership is formulating a strategy to bring another COVID-19 legislative package to the floor. On a caucus call yesterday, Speaker Nancy Pelosi (D-CA) stated that she is pushing Committee chairs to finalize their portions of the “CARES 2.0” legislation as soon as possible in the hopes of finalizing the package by the end of the week. Should House Democrats release finalized text by this week, the measure will likely be brought to the floor for a vote at some point next week. Democrats have reportedly been working off of Speaker Pelosi’s counteroffer to Senate Majority Leader Mitch McConnell’s (R-KY) original CARES Act as a starting point for developing their forthcoming bill, prioritizing funding for state and local governments, election assistance, workforce protections, and reforms to the Paycheck Protection Program (PPP), among other things.
Continue reading “Today on the Hill: Special COVID-19 Edition (5/5)”Capitol Hill Update
Senators will return this afternoon to resume legislative business, but the House will remain away from Washington amid health and safety concerns from the Attending Physician’s office. As the floor and Committee schedules for coming days and weeks take shape, leadership officials stated that Congress is likely to consider another round of COVID-19 legislation as they look to stem emerging and existing issues pertaining to the outbreak. For now, the Senate is expected to primarily focus on clearing judicial nominees and presidential nominations, starting with consideration of Robert Feitel’s nomination to be Inspector General of the Nuclear Regulatory Commission.
Continue reading “Health Policy Report (5/4)”Thorn Run Partners is proud to have been listed as a “top firm” for the first quarter of 2020 by POLITICO Influence — the leading government affairs beat in Washington, D.C. Since its founding in 2010, TRP has consistently ranked among Washington’s fastest growing lobbying firms according to analysis from Politico, The Hill, Bloomberg Government, and others. In the writeup of this announcement, TRP’s Andy Rosenberg was cited for his perspective on the current landscape for lobbying activity in the wake of the novel coronavirus (COVID-19) outbreak. “The current rush of lobbying activity will probably be followed by some degree of economic downturn, and that’s never good for anyone’s business,” said Rosenberg. “However, the fact that every public and private entity now realizes the importance of the federal government to their economic future should cut the other way for the better government affairs firms.”
Continue reading “Politico Lists TRP as ‘Top Firm’ for 2020 Q1”Capitol Hill Update
Senators will return this afternoon to resume legislative business, but the House will remain away from Washington amid health and safety concerns from the Attending Physician’s office. As the floor and Committee schedules for coming days and weeks take shape, leadership officials stated that Congress is likely to consider another round of COVID-19 legislation as they look to stem emerging and existing issues pertaining to the outbreak. For now, the Senate is expected to primarily focus on clearing judicial nominees and presidential nominations, starting with consideration of Robert Feitel’s nomination to be Inspector General of the Nuclear Regulatory Commission.
Continue reading “Today on the Hill: Special COVID-19 Edition (5/4)”Capitol Hill Update
Senators will return on Monday to resume legislative business, but the House will remain away from Washington amid health and safety concerns from the Attending Physician’s office. As the floor and Committee schedules for coming days and weeks takes shape, leadership officials stated that Congress is likely to consider another round of COVID-19 legislation as they look to stem emerging and existing issues pertaining to the outbreak. For now, the Senate is expected to primarily focus on clearing presidential nominations, starting with consideration of Robert Feitel’s nomination to be Inspector General of the Nuclear Regulatory Commission.
Continue reading “Today on the Hill: Special COVID-19 Edition (5/1)”
